Remove Bacteria Remove Bioinformatics Remove Development Remove Genetics
article thumbnail

Antibiotic resistance may spread even more easily than expected

Scienmag

Credit: Jan Zrimec/Chalmers University of Technology Pathogenic bacteria in humans are developing resistance to antibiotics much faster than expected. Now, computational research at Chalmers University of Technology, Sweden, shows that one reason could be significant genetic transfer between bacteria in our ecosystems and to humans.

article thumbnail

Full evolutionary journey of hospital superbug mapped for the first time

Scienmag

Modern hospitals and antibiotic treatment alone did not create all the antibiotic resistant strains of bacteria we see today. Instead, selection pressures from before widespread use of antibiotics influenced some of them to develop, new research has discovered.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

WHO launches global network to detect and prevent infectious disease threats

The Pharma Data

Pathogen genomics analyzes the genetic code of viruses, bacteria and other disease-causing organisms to understand how infectious they are, how deadly they are, and how they spread. Diseases do not respect borders: a disease threat in one country is also a threat to others.

Genome 52
article thumbnail

The microbiome in precision medicine

Drug Discovery World

An industry overview of the role of the microbiome in precision medicine, and its interplay with research tools, diagnostics, and therapeutic development. These novel tools are facilitating the exploration of the microbiome in diagnostics development and drug discovery.

article thumbnail

The future of genomic medicine: can it fulfil its promises?

pharmaphorum

Last week geneticist Dr Charles Steward shared with us his experiences of searching for a genetic cause for his children’s rare neurological diseases. If you are developing a drug, for example, for infantile epilepsy, then you need to know if your drug target is expressed in the brain and also during early development.

Genome 119